Mar 29, 2022 / 08:30PM GMT
Operator
Thank you for standing by. This is the conference operator. Welcome to the HTG Molecular Diagnostics, Inc. Fourth Quarter 2021 Earnings Conference Call. (Operator Instructions)
The conference is being recorded. (Operator Instructions)
I would now like to turn the conference over to Andrew Eriksen from LifeSci Advisors. Please go ahead.
Andrew Eriksen -
Before we begin the call, let me remind you that the company's remarks include forward-looking statements within the meaning of the federal securities laws, including statements regarding our expected revenue recovery, the importance of the company's HTG transcriptome panel, statements related to the company's HTG Therapeutics and Drug Discovery business, our future growth, business momentum and market opportunities and the expected capabilities of our technology. These forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond HTG's control, including uncertainties regarding the ongoing COVID-19 pandemic and its impacts on HTG and its customers that may cause
Q4 2021 HTG Molecular Diagnostics Inc Earnings Call Transcript
Mar 30, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers